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ABSTRACT  1 
The large variation in individual response to infection with Rift Valley fever virus 2 
(RVFV) suggests that host genetic determinants play a role in determining virus-3 
induced disease outcomes. These genetic factors are still unknown. The systemic 4 
inoculation of mice with RVFV reproduces major pathological features of severe 5 
human disease, notably the hepatitis and encephalitis. A genome scan performed 6 
on 546 (BALB/c  MBT) F2 progeny identified three quantitative trait loci (QTLs), 7 
denoted Rvfs-1 to Rvfs-3, that were associated with disease susceptibility in 8 
MBT/Pas mice. Non parametric interval-mapping revealed one significant and two 9 
suggestive linkages with survival time on chromosomes 2 (Rvfs-1), 5 (Rvfs-3), and 10 
11 (Rvfs-2) with respective LOD scores of 4.58, 2.95 and 2.99. The two-part model, 11 
combining survival time and survival/death, identified one significant linkage to 12 
Rvfs-2 and one suggestive linkage to Rvfs-1 with respective LOD scores of 5.12 and 13 
4.55. Under a multiple model, with additive effects and sex as a covariate, the three 14 
QTLs explained 8.3 % of the phenotypic variance. Sex had the strongest influence 15 
on susceptibility. The contribution of Rvfs-1, Rvfs-2, and Rvfs-3 to survival time of 16 
RVFV-infected mice was further confirmed in congenic mice. 17 
18 
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INTRODUCTION 1 
Rift Valley fever (RVF) is a serious emerging viral zoonosis that primarily affects 2 
ruminants and humans. Recurrent outbreaks have been documented in sub-3 
Saharan Africa and have spread outside continental Africa to Madagascar, and the 4 
Arabian Peninsula, killing hundreds of thousands of animals and more than a 5 
thousand humans.1,2  The RVF virus (RVFV), a member of the Bunyaviridae family, 6 
genus Phlebovirus, is mainly transmitted by mosquitos and causes necrotic 7 
hepatitis, hemorrhage and abortions with high mortality among newborn and 8 
young animals.3  Humans can also be infected through aerosols or by physical 9 
contact with body fluids, and organs of infected animals.4,5  Some reports indicated 10 
that the disease predominantly affects male patients,6  which could result from 11 
increased occupational and professional contacts with animals. Most patients 12 
suffer a self-limiting, febrile illness. However, a subset of patients develop severe 13 
forms characterized by hepatitis with fatal hemorrhagic fever or neurological 14 
disorders. The mortality rate has been reported to vary from 1 to 14%.7,8  Due to 15 
the possibility of acute disease and the ease of aerosolization of infectious viral 16 
particles, RVFV outbreaks and research are carefully monitored by government 17 
agencies to prevent its potential use in bioterrorism.9   18 
Progress in molecular biology of RVFV has been made during the last 19 
decade.10,11  The genome of RVFV consists of a single-stranded tripartite RNA (L, M, 20 
and S segments) of negative-sense or ambisense polarity. The L segment encodes 21 
the RNA-dependent RNA polymerase, while the M segment encodes the envelope 22 
glycoproteins (Gn/Gc) and the non-structural NSm protein. The S segment encodes 23 
the N nucleocapsid and the NSs nonstructural protein. The NSs protein is the major 24 
virulence factor counteracting both the antiviral interferon (IFN)-β response and 25 
the double-stranded RNA (dsRNA)-dependent protein kinase (PKR) activity.12-26 
14  Little is known about the natural host factors that influence the progression and 27 
severity of RVF disease in humans and animals. The large variation in individual 28 
response to the infectious agent suggests the existence of host genetic factors 29 
influencing susceptibility to RVF disease.1,2  At present, it is impossible to dissect 30 
host genetic determinants of RVF severity in humans, or livestock, as no one has 31 
access to the large number of cases required for a genome-wide association study 32 
  
 
 
4 
(GWAS). Animal models of RVF disease are needed to perform functional studies in 1 
a controlled setting,15  and to better define genetic susceptibility factors. The 2 
susceptibility of rats to RVFV differs among strains.16-18  Previous experiments with 3 
the rat model indicated a single Mendelian gene with dominant inheritance in the 4 
resistance phenotype of WF/mol rats although the underlying polymorphism has 5 
not yet been identified.19,20   6 
Mouse models have provided key insights into the biology of human diseases and 7 
paved the way for the development of novel therapeutic approaches.21  We have 8 
previously shown that wild-derived inbred MBT/Pas (MBT) mice are the most 9 
susceptible to infection with RVFV virulent strains, while BALB/cByJ (BALB/c) 10 
mice show the highest resistance among the tested strains.22  Following infection 11 
with the wild-type virus strain ZH548, MBT mice exhibited earlier and higher 12 
viremia compared to BALB/c mice. Interestingly, the susceptibility of MBT mice to 13 
RVF disease seems to be selective since these mice survived an infection with 14 
either influenza A virus or West Nile virus in conditions where BALB/c mice 15 
died.22  16 
To investigate the inheritance of susceptibility to RVF disease, we used a genome-17 
wide quantitative trait locus (QTL) search strategy. This method does not require 18 
prior hypotheses regarding the pathogenesis of the disease. The analysis of 19 
survival time identified three QTLs on chromosomes (Chr) 2, 5 and 11, designated 20 
Rift Valley fever virus susceptible locus (Rvfs)-1, -3 and -2 respectively. 21 
Chromosomal regions spanning the QTLs from the susceptible strain (MBT) were 22 
transferred into the resistant recipient (BALB/c) background. Each congenic strain 23 
(denoted C.MBT-Rvfs) carries a BALB/c genetic background with only the 24 
chromosomal segment encompassing the corresponding Rvfs locus from MBT. 25 
Phenotypic differences in the C.MBT-Rvfs-1, -2 and -3 congenic strains relative to 26 
BALB/c mice confirmed the effects of the three QTLs. Our data also support the 27 
existence of sex-specific genetic variants governing susceptibility to RVFV-induced 28 
disease. 29 
30 
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RESULTS 1 
Segregation analysis of the RVFV susceptible phenotype in BALB/c and MBT 2 
F2 cross 3 
In a previous study, we identified the MBT inbred strain, an inbred derivative of 4 
wild caught animals, as highly susceptible to infections with virulent strains of 5 
RVFV. When infected intraperitoneally with 100 PFU of RVFV ZH548 strain, most 6 
MBT mice died within 3 days while BALB/c animals survived longer.22  The 7 
difference of susceptibility between MBT and BALB/c mice indicates that host 8 
genetic factors control outcomes following infection with RVFV. In our 9 
experiments, MBT and BALB/c were considered as the susceptible and resistant 10 
strain, respectively. To investigate the mode of inheritance of MBT susceptibility to 11 
RVFV infection, we examined the mortality of 116 (BALB/c  MBT) F1 hybrids 12 
after RVFV infection (Figure 1A). Significant differences in sex-specific 13 
susceptibility were seen in F1 mice, as well as in parental BALB/c and MBT mice, 14 
the males were more susceptible than the females (log-rank test; P<0.0001 for 15 
BALB/c and F1; P<0.001 for MBT). The F1 population displayed similar survival 16 
curves as the BALB/c strain (log-rank test; P=0.1490 and 0.1381 for female and 17 
male mice, respectively),  while they were significantly different from the MBT 18 
strain (log-lank test; P<0.05 for both female and male mice). The mean time-to-19 
death in the F1 population (6.20±0.25 and 6.00±0.20 days for females and males) 20 
was significantly lower than that of BALB/c mice in both sexes (8.17±0.24 and 21 
6.70±0.21 days for females and males, respectively; surviving animals were not 22 
included; one-way ANOVA with Tukey’s post hoc test).  23 
F2 progeny were produced, infected with the RVFV and monitored. The F2 24 
population showed intermediate survival curves, significantly different from both 25 
parental strains (Figure 1A). Furthermore, the mean time to death of the F2 26 
population showed a continuous distribution within the range of parental 27 
phenotypes, suggesting a multigenic control (Figure 1B). Male mice presented a 28 
shorter time to death and a higher mortality rate than females in F2 populations 29 
(log-rank test; P<0.0001). 30 
 31 
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Genetic dissection of the susceptible phenotype in BALB/c and MBT F2 1 
intercross 2 
To identify genetic components underlying the susceptibility to RVFV infection in 3 
the MBT mice, a whole genome scan was performed to evaluate 546 (BALB/c  4 
MBT) F2 progeny. A total of 259 polymorphic markers located on all autosomal 5 
chromosomes and on the X chromosome were assayed. Out of 546 RVFV-infected 6 
mice, 41 individuals (7.5%) survived more than 9 days post-infection (p.i.). To map 7 
the QTLs, we applied methods developed by Broman which account for spikes in 8 
the phenotype distribution.23  A binary analysis of survival/death with sex as a 9 
covariate failed to reveal any significant QTLs, probably due to the small number of 10 
surviving mice. We performed nonparametric interval-mapping with the time to 11 
death after infection as a trait. Surviving mice were excluded, leaving 505 non-12 
surviving animals for analysis. One significant QTL was detected on Chr 2 with the 13 
peak LOD score reaching 4.58 at genomic position 168.2 Mb (P=0.005). Two 14 
suggestive QTLs were also found on Chr 5 (LOD=2.95; P=0.160 at genomic position 15 
61.6 Mb) and Chr 11 (LOD=2.99; P=0.154 at genomic position 113.9 Mb) (Figure 16 
2A). We also applied a two-part model, combining the binary trait 17 
(survival/death), and the quantitative trait (survival time)23 . One significant and 18 
one suggestive QTLs were detected on Chr 11 (LOD=5.12; P=0.022 at genomic 19 
position 112.8 Mb) and Chr 2 (LOD=4.55; P=0.075 at genomic position 168.2 Mb), 20 
respectively (Figure 2B). No significant QTLs were detected when these QTL tests 21 
were performed on females and males separately. Of note, the loci on Chr 2 and 11 22 
achieved the 5% genome-wide significance level only with the nonparametric 23 
interval-mapping and the two-part model, respectively. No QTLs were found on X 24 
chromosome which could have contributed to the sex difference in susceptibility. 25 
We then investigated the genetic interactions (additive or epistatic) between the 26 
three QTLs, using the scantwo command of R/qtl (Figure 3). This analysis provided 27 
evidence for significant additive effects between Chr 2 and 11 (LOD=6.86; 28 
P=0.014), and between Chr 2 and 5 (LOD=6.73; P=0.016). A suggestive additive 29 
effect was also detected between Chr 5 and 11 (LOD=5.85; P=0.089). There was no 30 
evidence for epistatic interactions. To estimate the effect of each QTL on the 31 
phenotype, we fitted a multiple-QTL model under the hypothesis that the three 32 
  
 
 
7 
QTLs on Chr 2, 5, and 11 contribute additively to the susceptibility to RVFV 1 
infection (as measured as the time to death) using sex as a covariate. As a result, 2 
we found that the QTLs collectively explain 8.3% of the phenotypic variance in the 3 
F2 population whereas sex had the strongest effect on the phenotype, explaining 4 
10.1% of the variance (Table 1). The three QTLs will be referred to as Rift Valley 5 
fever susceptible locus-1 (Rvfs1) on Chr 2, Rvfs2 on Chr 11 and Rvfs3 on Chr 5. The 6 
confidence intervals, based on two-LOD units drop-off from the QTL peaks, were 7 
determined by the markers D2Mit306 and rs3664044 for Rvfs1, rs13481186 and 8 
D11Mit69 for Rvfs2, and D5Mit125 and rs4225536 for Rvfs3 (Table 1).  9 
Derivation and susceptibility of congenic strains  10 
Congenic strains were generated in order to confirm the individual effects of Rvfs1, 11 
Rvfs2 and Rvfs3 on the susceptibility to the RVFV infection. The critical interval for 12 
each of the QTLs was transferred from the MBT genome onto a BALB/c genetic 13 
background by at least ten cycles of backcrossing using marker-assisted 14 
introgression. Two heterozygotes were then intercrossed and two homozygous 15 
offspring were bred to fix the MBT haplotype of Rvfs1, Rvfs2 and Rvfs3 on the 16 
BALB/c background, resulting in the C.MBT-Rvfs1, C.MBT-Rvfs2 and C.MBT-Rvfs3 17 
congenic strains. To characterize precisely the introgressed segments, congenic 18 
mice were analyzed using the MegaMUGA platform that includes 77.8K 19 
markers.24  The analysis revealed that the MBT segment on Chr 2 in C.MBT-Rvfs1 20 
spans from a point between 2:164,791,844 and 2:164,836,539 to the end of 21 
chromosome. Similarly, the MBT segment on Chr 11 in C.MBT-Rvfs2 spans from a 22 
point between 11:104,823,629 and 11:104,845,860 to the end of chromosome, and 23 
on Chr 5 in C.MBT-Rvfs3 spans from a point between 5:53,334,387 and 24 
5:53,365,815 to a point between 5:120,706,275 and 5:120,737,326 (Figure 4). No 25 
unlinked MBT markers were found in the congenic genomes, confirming that only 26 
the Rvfs chromosomal segments were introgressed onto the BALB/c genetic 27 
background. 28 
The three congenic strains were challenged with 100 PFU of RVFV ZH548 strain. In 29 
the C.MBT-Rvfs2 and C.MBT-Rvfs3 strains, the males were more susceptible than 30 
the females (log-rank test; P<0.001 and P<0.0001 respectively). Difference in sex-31 
specificity was not significant in C.MBT-Rvfs1 mice using cohort sizes of 16 females 32 
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and 20 males. C.MBT-Rvfs1 females died significantly earlier than BALB/c females, 1 
while no significant difference was observed between C.MBT-Rvfs1 and BALB/c 2 
males (Figure 4A). C.MBT-Rvfs2 mice of both genders died significantly earlier than 3 
BALB/c mice (Figure 4B). Finally, C.MBT-Rvfs3 males died significantly earlier than 4 
BALB/c males. These results confirmed the effects of the three QTLs on the 5 
susceptible phenotype. Unexpectedly, however, C.MBT-Rvfs3 females survived 6 
significantly longer than BALB/c females, an unexpected result which would 7 
require confirmation on a larger cohort (Figure 4C). No significant differences 8 
were observed between BALB/c mice and animals heterozygous for the 9 
haplotypes of Rvfs1, Rvfs2 or Rvfs3. This indicates that these QTLs have recessive 10 
effects while on the BALB/c genetic background. 11 
DISCUSSION 12 
Host genetic control of RVF disease in mice 13 
Susceptibility to infectious disease is difficult to assay in humans, and human 14 
GWAS would require tens or hundreds of thousands samples of RVFV-infected 15 
patients. Mice provide an alternative means of studying RVF disease since they 16 
recapitulate the acute-onset hepatitis and delayed-onset encephalitis seen in 17 
severe human RVF.25  The current study was designed to assess the effect of 18 
polymorphisms in the mouse genome on survival after infection with a virulent 19 
strain of the RVFV. Since previous attempts to identify an influence of genetic 20 
factors in classical laboratory strains have failed,20  we tested the susceptibility of 21 
inbred strains derived from progenitors of various Mus subspecies, and found that 22 
mice of the Mus m. musculus derived MBT strain exhibited an extreme 23 
susceptibility to RVFV infection.22  We show here that the susceptibility of MBT 24 
mice to RVFV infection is a complex trait that is inherited in a multifactorial 25 
fashion with sex influencing the severity of infection. We identified three host 26 
genome regions associated with severity of RVF disease in inbred mice. Each of 27 
these QTLs explains between 1.78% and 3.17% of the phenotypic variance. These 28 
results are consistent with data from a comprehensive analysis of the genetic 29 
architecture of behavioral and physiological phenotypes in the mouse which 30 
indicate that most QTLs explain between 1% and 5% of the genetic variance, and 31 
only 1% of the QTLs have an effect greater than 5%.26  QTLs with larger effect sizes 32 
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on survival time following infection were occasionally identified.27,28  Altogether, 1 
only 8.3% of the phenotypic variance in the (BALB/c  MBT)F2 could be ascribed 2 
to genetic determinants meaning that there must be many undetected loci. This 3 
suggests that susceptibility to RVFV infection is controlled by many variants of 4 
modest effect.  5 
We have previously shown that mouse embryonic fibroblasts derived from MBT 6 
mice lacked a complete type I IFN response, suggesting that inappropriate innate 7 
immune response could account for the susceptibility of MBT mice.22  A search for 8 
candidate genes using PosMed program29  with “innate immune response” as a 9 
keyword gave a list of 69, 105, and 180 genes for the critical interval as defined by 10 
C.MBT-Rvfs1, -Rvfs2 and -Rvfs3 congenic strains respectively. This high number of 11 
candidate genes was expected given the large size of the critical regions, 16.9 Mb, 12 
16.9 Mb, and 67.4 Mb, respectively. Therefore, the identification of the genes 13 
underlying the QTLs will first require the production of subcongenic strains for 14 
fine mapping to reach manageable numbers of candidate genes. Analysis of 15 
sequence variation between MBT and BALB/c genomes will also be performed. A 16 
drawback of using a wild-derived inbred strain is that the average divergence of 17 
approximately 1 SNP per 120 bp between M. m. musculus derived and laboratory 18 
genomes is higher than that observed between pairs of laboratory strains (1 SNP 19 
per 700 bp).30  This higher number of naturally occurring but functionally neutral 20 
polymorphic variants will complicate the identification of the causal mutation. 21 
Gene expression profiling in the target tissues of RVF disease from RVFV-infected 22 
C.MBT-Rvfs congenic and BALB/c control mice will also be of great utility. This 23 
combined effort will help narrow Rvfs QTLs to testable lists of candidate genes.  24 
Although this study is the first of its kind in the mouse, detailed analyses of RVFV-25 
infected inbred rats also demonstrated that the host genotype determines the 26 
outcome of RVF disease. First evidence suggesting variation among rodent inbred 27 
lines came from Peters and co-workers who showed that Wistar-Furth (WF) 28 
inbred rats are highly susceptible to liver necrosis induced by subcutaneous 29 
infection with RVFV, while Lewis (LEW) rats are largely resistant.17  Resistance to 30 
hepatitis in LEW rats was shown to be inherited as a simple Mendelian dominant 31 
trait,20  and derivation of a congenic line confirmed that a single chromosomal 32 
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region was able to confer the resistance of LEW rats to the hepatic disease induced 1 
by infection with RVFV in susceptible WF rats.19  The locus involved has not been 2 
further defined or mapped and thus its relationship to the QTLs defined in our 3 
study is unknown. Altogether, experiments in rodent models of RVFV infection 4 
support the hypothesis that the differences in pathogenesis between breeds of 5 
ruminants,31 ,32 ,33  and among human patients1  are in part the result of genetic 6 
factors that influence susceptibility to RVFV infection. 7 
Effect of sex in susceptibility to RVF disease in mice 8 
A variety of other factors can potentially influence the severity of RVF disease, e.g. 9 
the inoculation dose and virulence of the virus, the sex, and the immune status of 10 
the host. We observed a significant sex effect in mice, not only in the BALB/c and 11 
MBT parental strains, but also in the F1 and F2 populations, with enhanced 12 
susceptibility in males compared to females. In fact, sex was the main factor 13 
explaining variance in the F2, higher than all three QTLs together (Table 1). RVFV 14 
infection in mice demonstrated tropism for a variety of organs, including the 15 
ovaries.25  Consistent with this, the ovaries and uterus in females, the seminal 16 
vesicles, preputial glands, epididymis and testis in males were identified as a site of 17 
viral replication in mice infected with a recombinant RVFV expressing the Renilla 18 
reniformis luciferase.34  In rats, males were reported to be somewhat more 19 
susceptible than females, and castrated males were more resistant than intact 20 
rats.20  This suggests the implication of sex hormones on the regulation of genes 21 
that underlie resistance to RVF disease in rodents. This is in line with our finding 22 
that two of the three Rvfs QTLs have stronger effect in one of the sexes, in females 23 
for Rvfs1, and in males for Rvfs3.  24 
In humans, reduced susceptibility to viral infections among females have been 25 
reported, presumably because females mount higher immune responses than 26 
males.35  However, lower female mortality due to infectious diseases is not 27 
universal, and a reverse pattern of excess female mortality has been observed for 28 
measles and influenza.36,37  With regard to RVF disease, epidemiological studies in 29 
Saudi Arabia, Kenya, South Africa, Sudan, and Gabon indicate that men are more 30 
frequently infected by RVFV than women.6,8,38-42  Direct contact with animal 31 
tissues, blood or other body fluids was reported to be the most common risk factor 32 
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and route of transmission of RVFV to humans in South Africa and 1 
Kenya.38,39  Therefore enhanced male morbidity in these regions of Africa may be 2 
explained by the occupation of herding, which implies slaughtering and milking, 3 
predominantly performed by men.43  Infected men were also reported to be at 4 
higher risk than women to develop severe RVF disease and eventually 5 
die.38,43  Again, this may be the result of more frequent exposures to infected 6 
animals and their body fluids which provide opportunities for infection with large 7 
inocula of RVFV compared to the low number of infectious viral particles 8 
transmitted by bites from infected mosquitoes.44  It is however not excluded that 9 
the higher fatality ratio measured in male human patients has also a biological 10 
basis as seen in rodents. Further clinical and epidemiological investigations in 11 
humans and genetic studies in rodents are needed to understand these sex and/or 12 
gender differences. 13 
MATERIALS AND METHODS 14 
Mice and crosses  15 
BALB/cByJ (BALB/c) mice were purchased from Charles River Laboratories. The 16 
MBT/Pas (MBT) strain, derived from M. m. musculus progenitors trapped in 17 
Bulgaria in 1980,45  is maintained at the Institut Pasteur. Female BALB/c mice 18 
were mated with male MBT mice to produce F1 hybrids. (BALB/c × MBT) F1 mice 19 
were intercrossed to produce F2 progeny (n=546) for the genome scan. To develop 20 
congenic strains, female BALB/c mice were crossed with MBT male mice. F1 21 
females were backcrossed to BALB/c males and the BC1 progeny were genotyped 22 
for several polymorphic microsatellite markers within the QTL regions on Chr 2, 5 23 
or 11. Males that carried heterozygous alleles for one of the QTLs but not for the 24 
other two QTLs were selected as breeders for the next generation. By the fifth 25 
generation, all breeders were heterozygous for the MBT alleles in the targeted 26 
region but homozygous for the BALB/c alleles in the other two QTL chromosomal 27 
segments. After reaching the tenth generation, mice were intercrossed to obtain 28 
homozygous animals. All F2 and congenic mice carried mitochondria and Y 29 
chromosome from BALB/c and MBT inbred strain respectively. Experiments on 30 
live mice were conducted according to the French and European regulations on 31 
care and protection of laboratory animals (EC Directive 86/609, French Law 2001-32 
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486 issued on June 6, 2001) and the National Institutes of Health Animal Welfare 1 
(Insurance #A5476-01 issued on July 2, 2007). Experimental protocols were 2 
approved by the Animal Ethics Committee #1 of the Comité Régional d’Ethique 3 
pour l’Expérimentation Animale (CREEA), Ile de France (N°2012-0025), and carried 4 
out in compliance with Institut Pasteur Biosafety Committee. 5 
Virus production and mouse infection  6 
The RVFV strain ZH548, isolated from a male patient with the acute febrile illness 7 
at Zagazig fever hospital, Egypt (obtained from Centre National de Référence des 8 
Fièvres Hémorragiques Virales, Institut Pasteur, Lyon, France),46,47  was used for all 9 
infection studies. Virus was titrated by plaque assay on monolayers of Vero E6 10 
cells.48  Mice were bred under specific pathogen free conditions and were 11 
transferred one week before infection into a BSL-3 isolator to allow 12 
acclimatization. Groups of 9- to 13-week-old animals were infected 13 
intraperitoneally with 100 PFU of RVFV strain ZH548. Morbidity, mortality and 14 
clinical disease scores were monitored daily for 14 days following infection. 15 
Animals that survived were euthanized on the last day of the monitoring period. 16 
Survival curves of congenic animals represent the pooled data from four to twelve 17 
experiments. 18 
Genotyping and QTL mapping  19 
Tail biopsies were collected at weaning from F2 progeny and high-quality DNA 20 
was prepared by standard phenol-chloroform extraction. Genotyping of F2 mice 21 
was performed using the GoldenGate platform (Illumina Inc.). A total of 484 SNPs 22 
were genotyped. Out of them, 244 markers were polymorphic and gave reliable 23 
genotypes, covering the entire mouse genome. After the first analysis, 15 24 
polymorphic microsatellite markers in the QTL regions were added to better 25 
define those regions. An interval mapping for the survival phenotype was 26 
performed with the R/qtl software (version 2.15.1) for mapping quantitative trait 27 
loci under a non-parametric model (death/survival) or under the two-part model 28 
(death/survival, and survival time).23,27,49  Genome-wide thresholds for 29 
significance were determined by a 1,000-permutation test. QTL were considered 30 
to be significant when the LOD scores exceeded the 5% genome-wide threshold 31 
and suggestive when the LOD scores exceeded the 20% genome-wide threshold. 32 
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All significant and suggestive QTLs were assessed in a multiple-QTL model with 1 
sex as a covariate (formula=y~sex+Q1+Q2+Q3), using makeqtl and fitqtl functions 2 
in R/qtl, and the percentage of phenotypic variance was estimated. The 2-LOD 3 
units drop-off was used to estimate the 95% confidence interval of each QTL. Tail 4 
DNAs of congenic strains were collected and analyzed with the MegaMUGA 5 
genotyping microarray (Neogen/Geneseek, Lincoln, NE), a new 78,000-probe 6 
array based on the Illumina® Infinium platform.24  Markers on the MegaMUGA are 7 
distributed genome-wide with an average spacing of 33 kb. 8 
Statistical analysis  9 
Statistical analysis was performed using GraphPad Prism 5.0 software (GraphPad). 10 
Survival curves were compared by log-rank test.  11 
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Table 1. Analysis in a multiple QTL model with sex as a covariate 1 
 2 
 3 
 Position 
(Mb) 
Nearest 
marker 
LOD % 
variance 
explained 
P-value 2-LOD 
support 
interval 
Locus 
Sex   12.8 10.10 2.41e-
14 
  
Chr 
2 
168.2 rs27311433 4.2 3.17 7.32e-
05 
D2Mit306 -
rs3664044 
Rvfs1 
Chr 
11 
113.9 D11Mit214 3.8 2.88 0.00017 rs13481186 
– D11Mit69 
Rvfs2 
Chr 
5 
61.6 rs13478310 2.3 1.78 0.00452 D5Mit125 – 
rs4225536 
Rvfs3 
 4 
  5 
 6 
 7 
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FIGURE LEGENDS 1 
Figure 1. Survival time of BALB/c, MBT, F1, and F2 mice after infection with RVFV 2 
ZH548 strain. (A) Nine- to twelve-week-old BALB/c, MBT, F1, and F2 female and 3 
male mice were infected intraperitoneally with 100 PFU of the RVFV ZH548. The 4 
survival of individual female (top) and male (bottom) mice was monitored until 5 
day 10 post-infection. Kaplan-Meier survival plots were recorded (log-rank test; 6 
the number of animals per genotype is given within brackets; *, P<0.05; **, P<0.01; 7 
****, P<0.0001). (B) The distribution of F2 population and parental strains after 8 
infection with RVFV ZH548. Circles and triangles represent individual female and 9 
male mice, respectively. Depicted are the means and SD of female (n=43) and male 10 
(n=46) MBT mice, female (n=211) and male (n=360) F2 mice, and female (n=34) 11 
and male (n=40) BALB/c mice. Animals that survived more than 10 days post-12 
infection were not included. 13 
Figure 2. Genome-wide QTL scans for the outcome of RVFV infection in (BALB/c  14 
MBT) F2 mice. A total of 546 F2 animals were genotyped with 259 polymorphic 15 
markers, and infected with RVFV ZH548 intraperitoneally. The survival of 16 
individual mice was monitored daily for a period of 14 days. (A) Nonparametric 17 
interval-mapping with the time to death as a trait, includes the 505 mice that died. 18 
LOD score is plotted as a function of genomic position. One significant locus on 19 
chromosome 2 and two suggestive loci on chromosomes 5 and 11 are revealed. (B) 20 
Two-part model combining the time to death and the binary trait (survived/died) 21 
of all 546 F2 animals. The large red dotted line represents the LOD trace for the 22 
nonparametric analysis, the small blue dashed line represents the LOD trace for 23 
the analysis of the binary trait (survive versus death), and the continuous black 24 
line is the sum of the two separate analyses. One significant locus on chromosome 25 
11 and one suggestive locus on chromosome 2 are found. The horizontal lines 26 
represent the genome wide significance thresholds after 1,000 permutations 27 
(full
line, P=0.05; long dash, P=0.1; small dash, P=0.2).  28 
Figure 3. Close-up of two-dimensional genome scan on chromosomes 2, 5, and 11. 29 
The two-dimensional genome scan performed for the whole genome revealed 30 
additive effects between loci on chromosomes 2, 5, and 11. A close-up of the two-31 
  
 
 
20 
dimension scan on chromosomes 2, 5 and 11 is displayed with epistatic interaction 1 
in the lower right triangle, and additive effects in the upper left triangle. The color 2 
scale (right) indicates the additive LOD scores on the left and the interaction LOD 3 
scores on the right. The additive thresholds for significance levels 20% and 5% 4 
were calculated to be 5.25 and 6.15. The epistasis thresholds for the identification 5 
of novel interactions for significance levels 20% and 5% were 5.61 and 6.31. There 6 
is significant evidence in the upper left triangle for additive effects between loci on 7 
chromosomes 2 and 11, and between chromosomes 2 and 5, and suggestive 8 
evidence for additive effects between chromosomes 5 and 11. The results in the 9 
lower triangle indicate no significant evidence for epistatic interaction between 10 
chromosomes 2, 5, and 11. 11 
Figure 4. Schematic representation of the MBT genomic regions fixed in the 12 
congenic strains and the congenic strain survival curves. (A) Haplotype structure 13 
of the congenic segment of chromosome 2 in C.MBT-Rvfs1 (Rvfs1) congenic strain 14 
(left). The position of the MBT-derived chromosome 2 (grey) is shown on the 15 
BALB/c chromosome 2 background (black). Regions of unknown genotype are 16 
represented in white. Markers are identified along with their positions on the 17 
physical map (in bp). Kaplan-Meier survival plots of female and male Rvfs1 mice 18 
(right). The number of animals per genotype and gender is given within brackets. 19 
(B) Haplotype of the congenic segment of chromosome 11 in C.MBT-Rvfs2 (Rvfs2) 20 
(left) and Kaplan-Meier survival plots of female and male Rvfs2 mice (right). (C) 21 
Haplotype of the congenic segment of chromosome 5 in C.MBT-Rvfs3 (Rvfs3) mice 22 
(left) and Kaplan-Meier survival plots of female and male Rvfs3 mice (right). (log-23 
rank test; *, P<0.05, ***, P<0.001). 24 
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